Canada Negotiates Drug Prices w Pan-Canadian Consortium    Sunitinib & Pazopanib are most commonly prescribed off trial settings

Canada Negotiates Drug Prices w Pan-Canadian Consortium Sunitinib & Pazopanib are most commonly prescribed off trial settings

kidneycancer

2 years
46 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Aly-Khan Lalani, MD Dana Farber Cancer Institute, discusses Canada Negotiates Drug Prices w Pan-Canadian Consortium Sunitinib & Pazopanib are most commonly prescribed off trial settings at Kidney Cancer Association 2017 in Miami.
Up Next Autoplay